Dendritomas formed by fus allogenic human hepatocellular ion of mature dendritic cells with carcinoma cells activate autologous cytotoxic T lymphocytes

被引:19
作者
Chan, RCF
Xie, H
Zhao, GP
Xie, Y [1 ]
机构
[1] Hong Kong Univ Sci & Technol, Dept Biol, Kowloon, Hong Kong, Peoples R China
[2] Shanghai Inst Cell Biol, Shanghai 200032, Peoples R China
[3] Chinese Acad Sci, Shanghai Res Ctr Biotechnol, Shanghai, Peoples R China
关键词
hepatocellular carcinoma; dendritic cells; dendritomas; SMMC-7721; HP1;
D O I
10.1016/S0165-2478(02)00078-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mature dendritic cells (DCs) have highly expressed CD1a, MHC class I, MHC class II, B7-1, B7-2 and ICAM-I molecules, all of which are essential for activation of naive T cells. In this study, dendritomas were formed by fusion of hepatocellular carcinoma (HCC) SMMC-7721 cells with autologous DCs in vitro. DCs were obtained from adherent monocytes cultured in the presence of GM-CSF and IL-4 and were matured in monocyte-conditioned media. Expression of MHC class II and HCC-specific antigen by these dendritomas were determined using a specific murine anti-HCC monoclonal antibody (mAb) specific for HCC cell line SMMC-7721, and a murine anti-human HLA-DR mAb, and was also confirmed using bi-dimensional flow cytometry and immuno-histostaining. Dendritomas were co-cultured with autologous T cells, resulting in activation of T cell proliferation and priming of naive T cells to induce MHC class I restricted lysis of HCC SMMC-7721 cells. The results imply that these dendritomas may have potential for use in HCC immunotherapy. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:101 / 109
页数:9
相关论文
共 34 条
  • [1] Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood
    Bender, A
    Sapp, M
    Schuler, G
    Steinman, RM
    Bhardwaj, N
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1996, 196 (02) : 121 - 135
  • [2] Counterpoint. Cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccine
    Bhattachary-Chatterjee, M
    Baral, RN
    Chatterjee, SK
    Das, R
    Zeytin, H
    Chakraborty, M
    Foon, KA
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2000, 49 (03) : 133 - 141
  • [3] Bocchia M, 2000, HAEMATOLOGICA, V85, P1172
  • [4] Di Nicola M, 2000, HAEMATOLOGICA, V85, P202
  • [5] Clinical experience with autologous tumor cell lines for patient-specific vaccine therapy in metastatic melanoma
    Dillman, RO
    Nayak, SK
    Barth, NM
    DeLeon, C
    Schwartzberg, LS
    Spitler, LE
    Church, C
    O'Connor, AA
    Beutel, LD
    [J]. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 1998, 13 (03) : 165 - 176
  • [6] FUHRER JP, 1991, CANCER RES, V51, P2158
  • [7] Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells
    Gong, JL
    Chen, DS
    Kashiwaba, M
    Kufe, D
    [J]. NATURE MEDICINE, 1997, 3 (05) : 558 - 561
  • [8] Fusions of human ovarian carcinoma cells with autologous or allogeneic dendritic cells induce antitumor immunity
    Gong, JL
    Nikrui, N
    Chen, DS
    Koido, S
    Wu, ZK
    Tanaka, Y
    Cannistra, S
    Avigan, D
    Kufe, D
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (03) : 1705 - 1711
  • [9] Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells
    Gong, JL
    Avigan, D
    Chen, DS
    Wu, ZK
    Koido, S
    Kashiwaba, M
    Kufe, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (06) : 2715 - 2718
  • [10] GRUIJL TD, 1999, NAT MED, V5, P1124